4.7 Article

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis

Journal

ANNALS OF THE RHEUMATIC DISEASES
Volume 81, Issue 3, Pages 309-314

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2021-221794

Keywords

-

Categories

Funding

  1. American College of Rheumatology
  2. European Alliance of Associations for Rheumatology
  3. Vasculitis Foundation
  4. University of Pennsylvania Vasculitis Center

Ask authors/readers for more resources

The revised classification criteria for EGPA demonstrate strong performance characteristics and are validated for use in research.
Objective To develop and validate revised classification criteria for eosinophilic granulomatosis with polyangiitis (EGPA). Methods Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in five phases: (1) identification of candidate criteria items using consensus methodology, (2) prospective collection of candidate items present at the time of diagnosis, (3) data-driven reduction of the number of candidate items, (4) expert panel review of cases to define the reference diagnosis and (5) derivation of a points-based risk score for disease classification in a development set using least absolute shrinkage and selection operator logistic regression, with subsequent validation of performance characteristics in an independent set of cases and comparators. Results The development set for EGPA consisted of 107 cases of EGPA and 450 comparators. The validation set consisted of an additional 119 cases of EGPA and 437 comparators. From 91 candidate items, regression analysis identified 11 items for EPGA, 7 of which were retained. The final criteria and their weights were as follows: maximum eosinophil count >= 1x10(9)/L (+5), obstructive airway disease (+3), nasal polyps (+3), cytoplasmic antineutrophil cytoplasmic antibody (ANCA) or anti-proteinase 3-ANCA positivity (-3), extravascular eosinophilic predominant inflammation (+2), mononeuritis multiplex/motor neuropathy not due to radiculopathy (+1) and haematuria (-1). After excluding mimics of vasculitis, a patient with a diagnosis of small- or medium-vessel vasculitis could be classified as having EGPA if the cumulative score was >= 6 points. When these criteria were tested in the validation data set, the sensitivity was 85% (95% CI 77% to 91%) and the specificity was 99% (95% CI 98% to 100%). Conclusion The 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis demonstrate strong performance characteristics and are validated for use in research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?

Emine Duran, Levent Kilic, Gamze Durhan, Ahmet Cagkan Inkaya, Gulay Sain Guven, Gul Karakaya, Orhan Macit Ariyurek, Omer Karadag

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Transplantation

The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021

Hans-Joachim Anders, Jerome Loutan, Annette Bruchfeld, Gema M. Fernandez-Juarez, Juergen Floege, Dimitrios Goumenos, Kultigin Turkmen, Cees van Kooten, Eleni Frangou, Kate Stevens, Andreas Kronbichler, Marten Segelmark, Vladimir Tesar

Summary: This article presents the updated guidelines on the management of lupus nephritis (LN) released by the European League for Rheumatism (EULAR) and other organizations. The article compares the differences between these guidelines and highlights their significance in LN management.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Rheumatology

A new tool supporting the diagnosis of childhood-onset Behcet's disease: venous wall thickness

Erdal Atalay, Berna Oguz, Seher Sener, H. Nursun Ozcan, Erdal Sag, Ummusen Kaya Akca, Muserref Kasap Cuceoglu, Zeynep Balik, Jale Karakaya, Omer Karadag, Ozge Basaran, Ezgi Deniz Batu, Yelda Bilginer, Seza Ozen

Summary: This study found that children with Behcet's disease have increased lower extremity venous wall thickness, not only when they have vascular involvement but also when they do not. Therefore, lower extremity venous wall thickness may be a new criterion for supporting the diagnosis of childhood Behcet's disease.

RHEUMATOLOGY (2023)

Article Rheumatology

The provisional OMERACT ultrasonography score for giant cell arteritis

Christian Dejaco, Cristina Ponte, Sara Monti, Davide Rozza, Carlo Alberto Scire, Lene Terslev, George A. W. Bruyn, Dennis Boumans, Wolfgang Hartung, Alojzija Hocevar, Marcin Milchert, Uffe Moller Dohn, Chetan B. Mukhtyar, Markus Aschwanden, Philipp Bosch, Dario Camellino, Stavros Chrysidis, Giovanni Ciancio, Maria Antonietta D'Agostino, Thomas Daikeler, Bhaskar Dasgupta, Eugenio De Miguel, Andreas P. Diamantopoulos, Christina Duftner, Ana Agueda, Ulrich Fredberg, Petra Hanova, Ib Tonder Hansen, Ellen-Margrethe Hauge, Annamaria Iagnocco, Nevsun Inanc, Aaron Juche, Rositsa Karalilova, Toshio Kawamoto, Kresten Krarup Keller, Helen Isobel Keen, Tanaz A. Kermani, Minna J. Kohler, Matthew Koster, Raashid Ahmed Luqmani, Pierluigi Macchioni, Sarah Louise Mackie, Esperanza Naredo, Berit Dalsgaard Nielsen, Michihiro Ogasawara, Carlos Pineda, Valentin Sebastian Schafer, Luca Seitz, Alessandro Tomelleri, Karina D. Torralba, Kornelis S. M. van der Geest, Kenneth J. Warrington, Wolfgang A. Schmidt

Summary: This study aimed to develop an OMERACT ultrasonography score for monitoring disease activity in giant cell arteritis (GCA) and evaluate its metric properties. The study followed the OMERACT Instrument Selection Algorithm and conducted Delphi rounds and online reliability exercise. The results showed that the OGUS had good reliability and sensitivity in assessing disease activity in GCA and could be used in clinical trials.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Review Rheumatology

Novel aspects in the pathophysiology and diagnosis of glomerular diseases

Andreas Kronbichler, Ingeborg Bajema, Duvuru Geetha, Marcus Saeemann

Summary: This review focuses on five different kidney diseases commonly encountered in rheumatological and nephrological practice. The diseases differ in their etiology, speed of kidney function decline, responsiveness to immunosuppression/immunomodulation, and the deposition of immune deposits/complexes. However, the role of immune deposits in tissue damage remains uncertain.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Risk factors for serious infections in ANCA-associated vasculitis

Balazs Odler, Regina Riedl, Philipp Gauckler, Jae Il Shin, Johannes Leierer, Peter A. Merkel, William St Clair, Fernando Fervenza, Duvuru Geetha, Paul Monach, David Jayne, Rona M. Smith, Alexander Rosenkranz, Ulrich Specks, John H. Stone, Andreas Kronbichler

Summary: This study aimed to identify risk factors associated with severe infections in patients with antineutrophil cytoplasm antibody-associated vasculitis (AAV). The use of low-dose TMP/SMX was found to be associated with a reduced risk of severe infections in patients treated with either rituximab (RTX) or cyclophosphamide (CYC)/azathioprine (AZA). Reduced B cell subpopulations at the start of treatment may be a useful indicator of reduced immunocompetence.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Orthopedics

Association between outpatient follow-up and incidence of revision after knee and hip replacements: a population-based cohort study

Rafael Pinedo-Villanueva, Spyros Kolovos, Edward Burn, Antonella Delmestri, Lindsay K. K. Smith, Andrew Judge, Sarah R. R. Kingsbury, Martin H. H. Stone, Philip G. G. Conaghan

Summary: Follow-up visits after primary hip or knee replacement surgery have been recommended, but their benefits have not been specifically examined. This study found that patients attending follow-up visits had a higher risk of revision surgery.

BMC MUSCULOSKELETAL DISORDERS (2023)

Article Orthopedics

The Effect of Body Mass Index on the Relative Revision Rates of Cemented and Cementless Unicompartmental Knee Replacements An Analysis of Over 10,000 Knee Replacements from National Databases

Hasan R. Mohammad, Andrew Judge, David W. Murray

Summary: The study examined the performance of cemented and cementless UKRs in different BMI groups. It found that higher-BMI groups had higher revision rates for cemented UKRs, but not for cementless UKRs. Cementless fixation was associated with reduced long-term revision rates and lower risks of aseptic loosening and pain in the obese group.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2023)

Review Rheumatology

Safety and efficacy associated with long-term low-dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis

Andriko Palmowski, Sabrina M. Nielsen, Zhivana Boyadzhieva, Abelina Schneider, Anne Pankow, Linda Hartman, Jose A. P. Da Silva, John Kirwan, Siegfried Wassenberg, Christian Dejaco, Robin Christensen, Maarten Boers, Frank Buttgereit

Summary: The study aimed to assess the safety and efficacy of long-term low-dose glucocorticoids in Rheumatoid Arthritis (RA). The analysis found that low-dose glucocorticoids did not increase the risk of adverse events, except for a higher risk of infections. It also showed moderate to high evidence of improvement in disease activity and function in RA.

RHEUMATOLOGY (2023)

Article Rheumatology

Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica

Eugenio De Miguel, Pierluigi Macchioni, Edoardo Conticini, Corrado Campochiaro, Rositsa Karalilova, Sara Monti, Cristina Ponte, Giulia Klinowski, Irene Monjo-Henry, Paolo Falsetti, Zguro Batalov, Alessandro Tomelleri, Alojzija Hocevar

Summary: The objective of this study was to analyze the prevalence and characteristics of subclinical giant cell arteritis (GCA) in patients with polymyalgia rheumatica (PMR). The researchers used ultrasound to examine multiple arteries of PMR patients and found some of them had subclinical GCA. Patients with subclinical GCA were older, had longer morning stiffness duration, and more frequently reported hip pain compared to those without subclinical GCA. The optimal screening strategy to detect vasculitis in PMR needs further investigation.

RHEUMATOLOGY (2023)

Article Orthopedics

A Comparison of the Periprosthetic Fracture Rate of Unicompartmental and Total Knee Replacements

Hasan R. Mohammad, Karen Barker, Andrew Judge, David W. Murray

Summary: A matched study was performed to compare the periprosthetic fracture rates after TKR and UKR. The fracture rate after UKR was approximately twice as high as that after TKR within the first 3 months postoperatively. However, over the first 10 years, the cumulative fracture rate after TKR was almost twice as high as that after UKR. Fracture rates after both UKR and TKR were higher in women, patients aged 75 or older, and patients with normal weight.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2023)

Editorial Material Urology & Nephrology

The COVID-19 Pandemic: A Special Challenge for the Journal's Editors

Andreas Kronbichler, L. Parker Gregg, Joanne M. Bargman

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Meeting Abstract Urology & Nephrology

LONG-TERM SPARSENTAN TREATMENT IN FSGS IN THE DUET OPEN-LABEL EXTENSION (OLE)

Howard Trachtman, Tarak Srivastava, Vladimir Tesar, Kirk N. Campbell, Michelle N. Rheault, Radko Komers, Edward Murphy, Andy Prasad, Loreto Gesualdo

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Review Urology & Nephrology

An update on diagnosis and treatment of ANCA associated renal vasculitis

Kultigin Turkmen, Hakan Ozer, Vladimir Tesar

Summary: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are a group of diseases characterized by necrotizing inflammation of small vessels. Different subgroups of AAV, including GPA, MPA, and EGPA, are defined based on clinical features. Renal involvement is common in AAV, especially in MPA. The prognosis of untreated AAV is poor, but with appropriate immunosuppressive therapy, the 5-year renal survival rate can reach 70-75%. Challenges in the management of AAV include improving disease activity measures, determining optimal therapy duration, and exploring targeted therapies with fewer adverse effects.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2023)

Article Rheumatology

Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?

Zehra Ozsoy, Adem Ozdemir, Mustafa Ekici, Emre Bilgin, Levent Kilic, Sedat Kiraz, Zeynep Saribas, Burcin Sener, Omer Karadag

Summary: This study aimed to investigate the effects of immunosuppressive doses on the results of the QuantiFERON-TB Gold Plus (QFT-Plus) test in patients with Rheumatoid Arthritis (RA), as well as the impact of the TB2 tube in the QFT-Plus test. The results showed that higher doses of immunosuppressive drugs in RA patients led to a lower positive rate in the QFT-Plus test, and the addition of the TB2 tube improved the test sensitivity.

RHEUMATOLOGY INTERNATIONAL (2023)

No Data Available